What precautions should be taken for scabies?

Scabies is a highly contagious skin infestation caused by the mite Sarcoptes scabiei var. hominis. Effective management requires both appropriate treatment and strict adherence to preventive measures to avoid transmission, treatment failure, or recurrence.

First, all household members and close physical contacts—including sexual partners—must be treated simultaneously, even if asymptomatic, as mites can be transmitted before symptoms appear (typically 2–6 weeks in primary infestation, but only 1–4 days in reinfestation). Delayed or incomplete treatment of contacts is a leading cause of persistent or recurrent scabies.

Topical scabicides—such as 5% permethrin cream—are applied to cool, dry skin from the neck down (including under nails, between fingers and toes, in skin folds, and on genitalia), left on for 8–14 hours (usually overnight), then washed off. A second application is recommended one week later to eliminate newly hatched mites that may have survived the first treatment. Oral ivermectin (200 µg/kg) may be used in cases of crusted (Norwegian) scabies, treatment failure, or when topical therapy is impractical—but it is contraindicated in children under 15 kg and during pregnancy or lactation unless benefits outweigh risks.

Thorough environmental decontamination is essential: all clothing, bedding, and towels used within the prior 72 hours must be machine-washed in hot water (≥50°C/122°F) and dried on high heat, or dry-cleaned. Items that cannot be laundered should be sealed in plastic bags for at least 72 hours—mites cannot survive more than 3 days off human skin. Vacuuming upholstered furniture and car seats is advised; disinfectant sprays are unnecessary and ineffective against mites.

Patients often experience persistent pruritus for 2–4 weeks after successful treatment due to an allergic reaction to mite antigens and debris—a phenomenon known as post-scabetic itch. This does not indicate treatment failure or ongoing infestation. Symptomatic relief may include oral antihistamines, topical corticosteroids (e.g., triamcinolone 0.1%), and emollients. However, new burrows, papules, or vesicles appearing >2 weeks after treatment suggest treatment resistance, reinfection, or noncompliance—and warrant clinical reassessment.

Finally, patients with crusted scabies—characterized by hyperkeratotic plaques, massive mite burden (>1 million mites), and high transmissibility—require coordinated care, often involving repeated ivermectin doses combined with topical therapy and rigorous infection control precautions to prevent nosocomial outbreaks.